Publicaciones (221) Publicaciones de JOSÉ LUIS PÉREZ CASTRILLÓN

2024

  1. A Missense Variant in TP53 Could Be a Genetic Biomarker Associated with Bone Tissue Alterations

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

  2. High Frequencies of Genetic Variants in Patients with Atypical Femoral Fractures

    International Journal of Molecular Sciences, Vol. 25, Núm. 4

  3. MEFV gene mutation (c.229G>T) as a cause of fever of unknown origin

    European Journal of Internal Medicine

2023

  1. Animal Experimental Models in Bone Metabolic Disease

    International Journal of Molecular Sciences

  2. Effectiveness of Twitter Threads to Improve Medical Student Electrocardiogram (ECG) Reading-Skills. The TwittUVa-ECG Non-Randomized Pre-Post Study

    Medical Science Educator, Vol. 33, Núm. 6, pp. 1359-1369

  3. Genistein supplementation has no effects on vitamin D levels in healthy Spanish postmenopausal women

    International Journal for Vitamin and Nutrition Research

  4. Influence of non-osteoporotic treatments in patients on active anti-osteoporotic therapy: evidence from the OSTEOMED registry

    European Journal of Clinical Pharmacology, Vol. 79, Núm. 10, pp. 1333-1339

  5. Long-Term Treatment and Effect of Discontinuation of Calcifediol in Postmenopausal Women with Vitamin D Deficiency: A Randomized Trial

    Journal of Bone and Mineral Research, Vol. 38, Núm. 4, pp. 471-479

  6. Metabolomic patterns, redox-related genes and metals, and bone fragility endpoints in the Hortega Study

    Free Radical Biology and Medicine, Vol. 194, pp. 52-61

  7. Speech therapy and hyperbaric oxygen for aphasia after carbon monoxide intoxication

    Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc, Vol. 50, Núm. 1, pp. 3-7

2022

  1. Analysis of Bone Histomorphometry in Rat and Guinea Pig Animal Models Subject to Hypoxia

    International Journal of Molecular Sciences, Vol. 23, Núm. 21

  2. Association between genetic variants in oxidative stress-related genes and osteoporotic bone fracture. The Hortega follow-up study

    Gene, Vol. 809

  3. Clinical practice guidelines for postmenopausal, glucocorticoid-induced and male osteoporosis: 2022 update

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 13-33

  4. Comorbidity and osteoporotic fracture: approach through predictive modeling techniques using the OSTEOMED registry

    Aging Clinical and Experimental Research, Vol. 34, Núm. 9, pp. 1997-2004

  5. Executive summary clinical practice guideline of postmenopausal, glucocortcioid-induced and male osteoporosis (2022 update). Spanish Society for Bone and Mineral Metabolism Investigation (SEIOMM)

    Revista Clinica Espanola, Vol. 222, Núm. 7, pp. 432-439

  6. Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update)

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 5-12

  7. Genetic variants in obesity-related genes and the risk of osteoporotic fracture. The Hortega Follow-up Study

    Frontiers in bioscience (Landmark edition), Vol. 27, Núm. 1, pp. 32

  8. Improving hip fracture care in Spain: evolution of quality indicators in the Spanish National Hip Fracture Registry

    Archives of Osteoporosis, Vol. 17, Núm. 1

  9. Influence of Obesity on Bone Turnover Markers and Fracture Risk in Postmenopausal Women

    Nutrients, Vol. 14, Núm. 8

  10. Molecular Mechanisms Involved in Hypoxia-Induced Alterations in Bone Remodeling

    International Journal of Molecular Sciences, Vol. 23, Núm. 6